Mobile Menu - OpenMobile Menu - Closed

Hearing on “Improving Access to Care: Legislation to Reauthorize Key Public Health Programs”

Date: 
Wednesday, July 29, 2020 - 10:00am
Location: 
Virtual Hearing via Cisco Webex

The Subcommittee on Health of the Committee on Energy and Commerce held a remote hearing at 10 a.m. (EDT) on Wednesday, July 29, 2020.  The hearing is entitled, “Improving Access to Care: Legislation to Reauthorize Key Public Health Programs.” 

 

Key Documents

Memorandum from Chairman Pallone to the Subcommittee on Health

Opening Statement of Chairman Pallone as prepared for delivery

Opening Statement of Chairwoman Eshoo as prepared for delivery

 

Livestream

 

Legislation

H.R. 2075, the “School-Based Health Centers Reauthorization Act of 2019”

H.R. 4078, the “EARLY Act Reauthorization of 2019”

H.R. 4439, the “Creating Hope Reauthorization Act"

H.R. 4764, the “Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019” or the “TRANSPLANT Act of 2019”

H.R. 5373, the “United States Anti-Doping Agency Reauthorization Act of 2019”

 

Witnesses

Robert Boyd, M.C.R.P., M.Div.
President
School-Based Health Alliance

Testimony


Linda Goler Blount, M.P.H.
President and CEO
BlackWomen’s Health Imperative

Testimony


Nancy Goodman, M.P.P., J.D.
Founder and Executive Director
Kids v. Cancer

Testimony


Aaron Seth Kesselheim, M.D., J.D., M.P.H.
Professor of Medicine
Harvard Medical School

Testimony


Brian Lindberg
Chief Legal Officer and General Counsel
National Bone Marrow Donor Program

Testimony


Travis T. Tygart
Chief Executive Officer
U.S. Anti-Doping Agency

Testimony

 

Issues: